Bay­er, Dew­point to work on heart drug; Viking’s obe­si­ty man­u­fac­tur­ing plans

Plus, news about In­terius Bio­Ther­a­peu­tics, Hope Med­i­cine, PMV Phar­ma­ceu­ti­cals, Epi­to­pea, Alyssum Ther­a­peu­tics and a new de­men­tia tri­al ac­cel­er­a­tor in the UK:

Bay­er ex­er­cis­es op­tion to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER